FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Creative Compounds Glutathione 100 mg/mL Injectable Recall

Glutathione 100 mg/mL Injectable, 100mL Vial, Use as Directed, RX, Creative Compounds,…

Creative Compounds · Wilsonville, OR

Risk level
Class II
Reported by FDA
Sep 18, 2013
Recall ID
D-1019-2013
Check your lot numberHow we source this data

Summary

Creative Compounds recalled Glutathione 100 mg/mL Injectable starting Aug 23, 2013. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1019-2013 on Sep 18, 2013. Reason: Glutathione 100 mg/mL injectable human drug is recalled due to Out Of Specification results or potential bacterial contamination and it was reported as passing by a contract laboratory. Status: Terminated.

Why it was recalled

Glutathione 100 mg/mL injectable human drug is recalled due to Out Of Specification results or potential bacterial contamination and it was reported as passing by a contract laboratory.

Product description

Glutathione 100 mg/mL Injectable, 100mL Vial, Use as Directed, RX, Creative Compounds, Wilsonville, OR 97070.

Lot numbers, UPCs & expiration codes

Lot #: 20130715@12, Exp10/13/2013

Where it was sold

Oregon and Washington

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1019-2013
Classification
Class II
Status
Terminated
Recall initiated
Aug 23, 2013
FDA report date
Sep 18, 2013
Quantity
16 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Creative Compounds

Original FDA data

Every field from FDA enforcement report D-1019-2013, exactly as published.

Show all FDA fields
City
Wilsonville
State
OR
Status
Terminated
Country
United States
Event ID
66084
Address
8560 Sw Salish Ln Ste 100
Code information
Lot #: 20130715@12, Exp10/13/2013
Postal code
97070-9625
Report date
Sep 18, 2013
Product type
Drugs
Recall number
D-1019-2013
Classification
Class II
Recalling firm
Creative Compounds
Product quantity
16 vials
Termination date
Sep 16, 2013
Reason for recall
Glutathione 100 mg/mL injectable human drug is recalled due to Out Of Specification results or potential bacterial contamination and it was reported as passing by a contract laboratory.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Glutathione 100 mg/mL Injectable, 100mL Vial, Use as Directed, RX, Creative Compounds, Wilsonville, OR 97070.
Distribution pattern
Oregon and Washington
Recall initiation date
Aug 23, 2013
Initial firm notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Center classification date
Sep 10, 2013

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1019-2013, published Sep 18, 2013. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls